SOURCE: Laser Energetics, Inc.

February 19, 2013 09:30 ET

Laser Energetics Announces the Dazer Laser® GUARDIAN Is Compliant With FDA Safety Regulations

MERCERVILLE, NJ--(Marketwire - Feb 19, 2013) - Laser Energetics, Inc. (PINKSHEETS: LNGT) today reported that its Dazer Laser® GUARDIAN is fully compliant with the FDA's Center for Devices and Radiological Health (CDRH) - 21 CFR 1040.10 standard for laser products. The GUARDIAN is the first of the Dazer Laser® Product Line to be in compliance with this important FDA requirement. The FDA 21 CFR 1040.10 standard sets the performance and labeling requirements that all laser products must meet prior to shipment for commercial and government entities throughout the United States. 

The Company recently retained Jerome Dennis to assist the Company in bringing the Dazer Laser® Products into full compliance with the requirements of the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA). Mr. Dennis retired with more than three decades of experience within that agency, where he served as the International Expert in Lasers and Optical Radiation Safety and Safety Standards. He has had the highest leadership roles such as the Chairman of the International Electrotechnical Commission Technical Committee 76 on optical radiation safety and laser products and as Past Vice Chairman of the ANSI Z136 standards committee. 

Mr. Dennis stated, "The Laser Energetics Dazer Laser® GUARDIAN is now compliant with the FDA 21 CFR 1040.10 performance standard for lasers and laser products. In working with the Company through the GUARDIAN's successful compliance to the FDA and US Government Regulations, the first of the Dazer Laser® Products, I found that the GUARDIAN required very minimal changes which ensured compliance with the standard, making this a very short and smooth process."

Robert D. Battis, Founder, President & CEO of Laser Energetics, Inc., stated, "The GUARDIAN's successful compliance to the critically important FDA 21 CFR 1040 standard is extremely exciting news that provides significant credibility and acceptance of our GUARDIAN system to the US Military, Commercial and Foreign marketplace. Compliance now removes the limits on sales for Test & Evaluation orders and provides the Company the ability to deliver unlimited order sizes to Law Enforcement Agencies and the US Federal Government. On behalf of Laser Energetics, I would like to thank our loyal shareholders for their continued support as we continue to break through the Optical Distractor markets with our Dazer Laser® Products. Successful FDA Compliance solidifies our rapidly expanding position throughout the World."

About Laser Energetics: The Company has a primary focus on its Dazer Laser® - Light Fighting Technologies, its Alexandrite Laser technology and its applications associated with Remote Sensing, Pill Marking, and Photo Acoustic Imaging as well as its Total Reflectance Transmitter (TRT) technology. Laser Energetics has and continues to develop a comprehensive and strategic laser product line that addresses laser applications in Industry, Science, Medicine, Homeland Security and the Military. More information about the company is available on the Internet at

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.

Contact Information

  • For additional information please contact Investor Relations:
    Mike Little
    (609) 610-4095